Targeting endothelial metaflammation to counteract diabesity cardiovascular risk: Current and perspective therapeutic options

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Pharmacological Research

• Publication date

  2017-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.phrs.2017.04.009PMID 28408314
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Apigenin and its methylglyoxal-adduct inhibit advanced glycation end products-induced oxidative stress and inflammation in endothelial cells.

  2019cited by this paper
• Considerations for management of patients with diabetic macular edema: Optimizing treatment outcomes and minimizing safety concerns through interdisciplinary collaboration.

  2017cited by this paper
• Rutin protects endothelial dysfunction by disturbing Nox4 and ROS-sensitive NLRP3 inflammasome.

  2017cited by this paper
• Endothelial dysfunction and vascular disease – a 30th anniversary update

  2017cited by this paper
• The opposing roles of NO and oxidative stress in cardiovascular disease.

  2017cited by this paper
• Bioactive polyphenols and cardiovascular disease: chemical antagonists, pharmacological agents or xenobiotics that drive an adaptive response?

  2017cited by this paper
• Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium

  2017cited by this paper
• Macro‐ and microvascular endothelial dysfunction in diabetes

  2017cited by this paper
• Personalized medicine in diabetes: the role of ‘omics’ and biomarkers

  2016cited by this paper
• Pharmacogenetic studies update in type 2 diabetes mellitus.

  2016cited by this paper
• Natural Compounds as Regulators of NLRP3 Inflammasome-Mediated IL-1β Production

  2016cited by this paper
• AMPK as a New Attractive Therapeutic Target for Disease Prevention: The Role of Dietary Compounds AMPK and Disease Prevention.

  2016cited by this paper
• Enhancement of endothelial permeability by free fatty acid through lysosomal cathepsin B-mediated Nlrp3 inflammasome activation

  2016cited by this paper
• Infliximab therapy restores adiponectin expression in perivascular adipose tissue and improves endothelial nitric oxide-mediated vasodilation in mice with type 1 diabetes.

  2016cited by this paper
• Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials

  2016cited by this paper
• Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents

  2016cited by this paper
• Anti-inflammatory treatment improves high-density lipoprotein function in rheumatoid arthritis

  2016cited by this paper
• Pharmacological Inhibition of NLRP3 Inflammasome Attenuates Myocardial Ischemia/Reperfusion Injury by Activation of RISK and Mitochondrial Pathways

  2016cited by this paper
• Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice

  2016cited by this paper
• Comparative review of dipeptidyl peptidase‐4 inhibitors and sulphonylureas

  2016cited by this paper
• Clinical implications of oxidative stress and potential role of natural antioxidants in diabetic vascular complications.

  2016cited by this paper
• Endothelial and Metabolic Function Interactions in Overweight/Obese Children.

  2016cited by this paper
• Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications

  2016cited by this paper
• Cardiovascular and non‐cardiovascular safety of dipeptidyl peptidase‐4 inhibition: a meta‐analysis of randomized controlled cardiovascular outcome trials

  2016cited by this paper
• Inhibition of Mitochondrial Fission and NOX2 Expression Prevent NLRP3 Inflammasome Activation in the Endothelium: The Role of Corosolic Acid Action in the Amelioration of Endothelial Dysfunction

  2016cited by this paper
• Erratum to: Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials

  2016cited by this paper
• Adiponectin signaling and function in insulin target tissues

  2016cited by this paper
• Adiponectin limits monocytic microparticle-induced endothelial activation by modulation of the AMPK, Akt and NFκB signaling pathways.

  2016cited by this paper
• Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis.

  2016cited by this paper
• Phosphorylation of Janus kinase 1 (JAK1) by AMP-activated protein kinase (AMPK) links energy sensing to anti-inflammatory signaling

  2016cited by this paper
• Fish-oil-derived n-3 polyunsaturated fatty acids reduce NLRP3 inflammasome activity and obesity-related inflammatory cross-talk between adipocytes and CD11b(+) macrophages.

  2016cited by this paper
• Targeting the NLRP3 inflammasome to Reduce Diet-induced Metabolic Abnormalities in Mice

  2015cited by this paper
• Instigation of endothelial Nlrp3 inflammasome by adipokine visfatin promotes inter‐endothelial junction disruption: role of HMGB1

  2015cited by this paper
• Endothelial Nlrp3 inflammasome activation associated with lysosomal destabilization during coronary arteritis.

  2015cited by this paper
• New forms of insulin and insulin therapies for the treatment of type 2 diabetes.

  2015cited by this paper
• Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse

  2015cited by this paper
• The prevention and treatment of hypoadiponectinemia-associated human diseases by up-regulation of plasma adiponectin.

  2015cited by this paper
• Astragaloside IV and cycloastragenol are equally effective in inhibition of endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation in the endothelium.

  2015cited by this paper
• Vascular Protection with Dipeptidyl Peptidase‐IV inhibitors in Diabetes: Experimental and Clinical Therapeutics

  2015cited by this paper
• Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Diabetes Mellitus.

  2015cited by this paper
• Metformin regulates differentiation of bone marrow-derived endothelial progenitor cells via multiple mechanisms.

  2015cited by this paper
• Purple sweet potato color inhibits endothelial premature senescence by blocking the NLRP3 inflammasome.

  2015cited by this paper
• Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in diabetic patients: A meta-analysis.

  2015cited by this paper
• Metformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the Endothelium

  2015cited by this paper
• PKC-β activation inhibits IL-18-binding protein causing endothelial dysfunction and diabetic atherosclerosis.

  2015cited by this paper
• Recent Advances in Dipeptidyl-Peptidase-4 Inhibition Therapy: Lessons from the Bench and Clinical Trials

  2015cited by this paper
• Dipeptidyl peptidase-4 inhibitors and their potential role in the management of atherosclerosis--A review.

  2015cited by this paper
• GLP-1R Agonists and Endothelial Dysfunction: More Than Just Glucose Lowering?

  2015cited by this paper
• Role of mitochondrial dysfunction in hyperglycaemia-induced coronary microvascular dysfunction: Protective role of resveratrol

  2015cited by this paper
• Protective Effect of Vitamin E against Diabetes-Induced Oxidized LDL and Aorta Cell Wall Proliferation in Rat

  2015cited by this paper
• NLRP3 Inflammasome Polymorphism and Macrovascular Complications in Type 2 Diabetes Patients

  2015cited by this paper
• Investigation into the association between NLRP3 gene polymorphisms and susceptibility to type 2 diabetes mellitus.

  2015cited by this paper
• Metformin improves endothelial function in aortic tissue and microvascular endothelial cells subjected to diabetic hyperglycaemic conditions.

  2015cited by this paper
• SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials

  2015cited by this paper
• A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond

  2015cited by this paper
• Exploring the various aspects of the pathological role of vascular endothelial growth factor (VEGF) in diabetic retinopathy.

  2015cited by this paper
• Circulating endothelial progenitor cells: Do they live up to their name?

  2015cited by this paper
• Review of head‐to‐head comparisons of glucagon‐like peptide‐1 receptor agonists

  2015cited by this paper
• Dapagliflozin treatment for type 2 diabetes: a systematic review and meta‐analysis of randomized controlled trials

  2014cited by this paper
• Procyanidin B2 inhibits NLRP3 inflammasome activation in human vascular endothelial cells.

  2014cited by this paper
• Comparison of bevacizumab and ranibizumab in age-related macular degeneration: a systematic review and meta-analysis.

  2014cited by this paper
• SGLT-2 Inhibitors: A New Mechanism for Glycemic Control

  2014cited by this paper
• Adiponectin and insulin cross talk: the microvascular connection.

  2014cited by this paper
• Modeling effects of SGLT‐2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes

  2014cited by this paper
• The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats

  2014cited by this paper
• Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?

  2014cited by this paper
• A review on PARP1 inhibitors: Pharmacophore modeling, virtual and biological screening studies to identify novel PARP1 inhibitors.

  2014cited by this paper
• Increased Antioxidant Defense Mechanism in Human Adventitia-Derived Progenitor Cells Is Associated with Therapeutic Benefit in Ischemia

  2014cited by this paper
• The safety of dipeptidyl peptidase‐4 (DPP‐4) inhibitors or sodium‐glucose cotransporter 2 (SGLT‐2) inhibitors added to metformin background therapy in patients with type 2 diabetes mellitus: a systematic review and meta‐analysis

  2014cited by this paper
• Glucagon-like peptide-1: glucose homeostasis and beyond.

  2014cited by this paper
• Recent advances in the molecular genetics of type 2 diabetes mellitus.

  2014cited by this paper
• AMPK activation: a therapeutic target for type 2 diabetes?

  2014cited by this paper
• DPP-4 Inhibitors Repress NLRP3 Inflammasome and Interleukin-1beta via GLP-1 Receptor in Macrophages Through Protein Kinase C Pathway

  2014cited by this paper
• Vascular oxidative stress, nitric oxide and atherosclerosis.

  2014cited by this paper
• Introduction to Personalized Medicine in Diabetes Mellitus

  2014cited by this paper
• Glucagon-Like Peptide-1 (GLP-1) Analog Liraglutide Inhibits Endothelial Cell Inflammation through a Calcium and AMPK Dependent Mechanism

  2014cited by this paper
• Anti‐inflammatory effects of exendin‐4, a glucagon‐like peptide‐1 analog, on human peripheral lymphocytes in patients with type 2 diabetes

  2013cited by this paper
• Can intake of extra antioxidants delay the development and progression of atherosclerosis?

  2013cited by this paper
• Antioxidant Micronutrients and Cardiovascular Risk in Patients with Diabetes: A Systematic Review

  2013cited by this paper
• Acute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculation

  2013cited by this paper
• The NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders

  2013cited by this paper
• Variants of NLRP3 gene are associated with insulin resistance in Chinese Han population with type-2 diabetes.

  2013cited by this paper
• Adipo-Myokines: Two Sides of the Same Coin—Mediators of Inflammation and Mediators of Exercise

  2013cited by this paper
• Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial.

  2013cited by this paper
• Efficacy, Safety, and Tolerability of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus: An Integrated Analysis of the DURATION Trials

  2013cited by this paper
• Antioxidant supplements and mortality

  2013cited by this paper
• Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout.

  2013cited by this paper
• INTRAVITREAL BEVACIZUMAB IN THE TREATMENT OF DIABETIC OCULAR NEOVASCULARIZATION

  2013cited by this paper
• The influence of perivascular adipose tissue on vascular homeostasis

  2013cited by this paper
• Effects of Dapagliflozin on Cardiovascular Risk Factors

  2013cited by this paper
• Vitamin C Further Improves the Protective Effect of Glucagon-Like Peptide-1 on Acute Hypoglycemia-Induced Oxidative Stress, Inflammation, and Endothelial Dysfunction in Type 1 Diabetes

  2013cited by this paper
• Bevacizumab for the management of diabetic macular edema.

  2013cited by this paper
• Dipeptidyl Peptidase‐4 Inhibitors Attenuate Endothelial Function as Evaluated by Flow‐Mediated Vasodilatation in Type 2 Diabetic Patients

  2013cited by this paper
• Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats.

  2013cited by this paper
• Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes

  2013cited by this paper
• The effect of the oral PKC β inhibitor ruboxistaurin on vision loss in two phase 3 studies.

  2013cited by this paper
• Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1

  2013cited by this paper
• Reversal of the deleterious effects of chronic dietary HFCS-55 intake by PPAR-δ agonism correlates with impaired NLRP3 inflammasome activation.

  2013cited by this paper
• A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity

  2013cited by this paper
• Poly (ADP-Ribose) Polymerase Mediates Diabetes-Induced Retinal Neuropathy

  2013cited by this paper

• Diabesity and cardiovascular mortality in a prospective population cohort followed for more than 20 years.

  2025cites this paper
• Influence of Bariatric Surgery on Endothelial and Glycocalyx Biomarkers in Obesity and Type 2 Diabetes

  2025cites this paper
• Endothelial Dysfunction in Obesity and Therapeutic Targets.

  2024cites this paper
• Diet control and BMI impact on Metformin response in type 2 Diabetes mellitus patients.

  2024cites this paper
• Current View on How Human Gut Microbiota Mediate Metabolic and Pharmacological Activity of Panax ginseng. A Scoping Review.

  2024cites this paper
• Diabetes mellitus and heart failure — a modern look at the mechanisms of development

  2022cites this paper
• Mediterranean Diet for the Prevention of Gestational Diabetes in the Covid-19 Era: Implications of Il-6 In Diabesity

  2021influential citation
• C-Reactive Protein as a Risk Marker for Post-Infarct Heart Failure over a Multi-Year Period

  2021influential citation
• Roles and Mechanisms of Dipeptidyl Peptidase 4 Inhibitors in Vascular Aging

  2021cites this paper
• Diabetes and Alzheimer’s Disease: Might Mitochondrial Dysfunction Help Deciphering the Common Path?

  2021cites this paper
• Prevalencia de diabesidad en población laboral española: influencia de variables sociodemográficas y consumo de tabaco

  2021cites this paper
• Diet and Chronic Non-Cancer Pain: The State of the Art and Future Directions

  2021cites this paper
• The Intrinsic Virtues of EGCG, an Extremely Good Cell Guardian, on Prevention and Treatment of Diabesity Complications

  2020cites this paper
• The hidden role of NLRP3 inflammasome in obesity‐related COVID‐19 exacerbations: Lessons for drug repurposing

  2020cites this paper
• Predictive efficacy of neutrophil-to-lymphocyte ratio for long-term prognosis in new onset acute coronary syndrome: a retrospective cohort study

  2020cites this paper
• Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus?

  2019cites this paper
• Endoplasmic reticulum stress and development of insulin resistance in adipose, skeletal, liver, and foetoplacental tissue in diabesity.

  2019cites this paper
• Altered foetoplacental vascular endothelial signalling to insulin in diabesity.

  2019cites this paper
• Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure

  2018cites this paper
• Reduced Susceptibility to Sugar-Induced Metabolic Derangements and Impairments of Myocardial Redox Signaling in Mice Chronically Fed with D-Tagatose when Compared to Fructose

  2018cites this paper
• The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin

  2018cites this paper
• Protective effects by co-administration of eicosapentaenoic acid, capsaicin, and dextrin against obesity-related metabolic dysregulation in ob/ob mice

  2018cites this paper
• Salusin-β Is Involved in Diabetes Mellitus-Induced Endothelial Dysfunction via Degradation of Peroxisome Proliferator-Activated Receptor Gamma

  2017cites this paper